Search company, investor...

Vascular Pathways


Acquired | Acquired

Total Raised


About Vascular Pathways

Vascular Pathways is a private medical devices company founded in 2005 involved in the commercialization of innovative vascular access devices. The AccuCath Intravenous Catheter System is an FDA cleared device enabling rapid, safe, and successful peripheral IV insertion.

Headquarters Location

1916 Fallen Leaf Lane

Los Altos, California, 94024,

United States


Missing: Vascular Pathways's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Vascular Pathways's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Vascular Pathways

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Vascular Pathways is included in 2 Expert Collections, including Medical Devices.


Medical Devices

11,721 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

Vascular Pathways Patents

Vascular Pathways has filed 26 patents.

The 3 most popular patent topics include:

  • Catheters
  • Medical equipment
  • Dosage forms
patents chart

Application Date

Grant Date


Related Topics




Medical equipment, Catheters, Dosage forms, Drug delivery devices, Medical treatments


Application Date


Grant Date



Related Topics

Medical equipment, Catheters, Dosage forms, Drug delivery devices, Medical treatments



Latest Vascular Pathways News

Vascular Pathways, Inc. Signs Agreement With HealthTrust for AccuCath(R) Line of Catheters

May 19, 2015

May 19, 2015 09:00 ET Vascular Pathways, Inc. Signs Agreement With HealthTrust for AccuCath® Line of Catheters BOCA RATON, FL--(Marketwired - May 19, 2015) - Vascular Pathways, Inc., a privately held medical device manufacturer with innovative wire-guided technology for peripheral intravascular access, today announced an agreement with HealthTrust, a leading group purchasing and total cost management organization that serves 1,350 acute care facilities nationwide, for AccuCath® catheters. The agreement became effective May 1, 2015. The agreement provides HealthTrust member facilities access to exclusive rates on Vascular Pathways, Inc.’s proprietary line of coiled-tip, wire-guided catheters designed to increase first attempt success, reduce complication rates, extend dwell times, increase patient satisfaction and lower overall costs to the provider. “We are excited to provide our proprietary line of intravascular catheters to HealthTrust’s membership across the nation,” said Bill Bold, president and CEO. “We look forward to helping improve patient outcomes and lower healthcare costs.” About Vascular Pathways Founded in 2005 by Amir Belson, M.D., Vascular Pathways is a medical device company commercializing the AccuCath® IV Catheter System line, an FDA-cleared, guidewire catheter system enabling rapid, safe and successful IV insertion. Vascular Pathways, Inc. is privately held by CHL Medical Partners, Ascension Health Ventures and MVM Life Sciences. For further information about Vascular Pathways or the AccuCath® IV catheter line, visit or call 844-VASPATH. About HealthTrust HealthTrust (legally known as Healthtrust Purchasing Group, L.P.) is committed to strengthening provider performance and clinical excellence through an aligned membership model and the delivery of total cost management solutions, including supply chain solutions and a contract and service portfolio unparalleled in quality, scope and value. HealthTrust ( ) serves 1,350 acute care facilities and members in more than 15,000 other locations, including ambulatory surgery centers, physician practices, long-term care and alternate care sites. Headquartered in Brentwood, Tennessee, HealthTrust is closely integrated with the proven capabilities of Parallon Business Solutions, LLC ( ), a leading provider of healthcare business and operational services, including revenue cycle management, workforce and technology solutions. On Twitter @healthtrustpg and @parallonconnect. Contact Information

Vascular Pathways Frequently Asked Questions (FAQ)

  • Where is Vascular Pathways's headquarters?

    Vascular Pathways's headquarters is located at 1916 Fallen Leaf Lane, Los Altos.

  • What is Vascular Pathways's latest funding round?

    Vascular Pathways's latest funding round is Acquired.

  • How much did Vascular Pathways raise?

    Vascular Pathways raised a total of $24.53M.

  • Who are the investors of Vascular Pathways?

    Investors of Vascular Pathways include C.R. Bard, Square 1 Bank, CHL Medical Partners, Ascension Ventures, Arcus Ventures and 4 more.

  • Who are Vascular Pathways's competitors?

    Competitors of Vascular Pathways include Sonoma Orthopedic Products, Pivot Medical, MAKO Surgical, GRAFTcath, Hemosphere and 11 more.

Compare Vascular Pathways to Competitors


GRAFTcath is a medical device company developing vascular access products for hemodialysis.

ExploraMed V

ExploraMed is a medical technology incubation company dedicated to the identification, creation and development of medical device solutions. ExploraMed creates ideas in the fields of clinical, engineering, legal, strategic marketing, and financing, while focusing on efficient and timely development.

Vascular Closure Systems

a medical device company, based in part on intellectual property of CardioVascular Technologies, Inc. (, and is focused on the development and commercialization of the vascular access closure technology for the Interventional Cardiology market. The company is comprised of several seasoned medical device professionals and physicians, with a proven record of innovation, clinical acumen, access to the industry and successful commercialization of multiple medical device technologies.

OmniSonics Medical Technologies

OmniSonics was a medical device company focused on developing breakthrough products for the treatment of vascular occlusive disease.

Claros Diagnostics

Claros Diagnostics is an early stage device company developing a POC multiplex diagnostic focused on a biomarker panel for prostate cancer.


VytronUS is developing an integrated imaging and ablation platform for cardiac electrophysiologists. Harnessing the capability of ultrasound energy, the company's system creates a high resolution image of the interior of the heart for procedure planning and allows the physician to draw a desired treatment pattern on the image at the workstation.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.